>>> US Gapping up

Gapping up
In reaction to earnings/guidance:

PINS +16.6%, LUNG +12.9%, WOLF +12.7%, GPRE +11.1%, ANET +10.4%, SSTK +10%, TREX +8.5%, GPN +7.9%, VRNS +6.8%, RYI +5.9%, KMPR +5.4%, ZBRA +5.4%, OTTR +5%, XYL +4.9%, HRMY +4.8%, MPWR +4.5% (also announced $640 mln for repurchases), CCJ +4.3%, BUD +4.1%, ETN +3.9%, QGEN +3.7%, COCO +3.6%, STLA +3.5%, DEA +3.4%, ARGX +2.9%, RGEN +2.9%, KFRC +2.7%, THC +2.5%, AGCO +2.5%, CWK +2.1%, TWO +2.1%, ABEV +2.1%, BLD +2.1%, OGS +2%, AGNC +2%, SITC +2% (also spinning off its Convenience portfolio), GPK +2%, ACGL +1.9%, AME +1.9%, INCY +1.9%, NBIX +1.7%, INST +1.6%, ALLE +1.5%, GVA +1.5%, ETRN +1.4%, LDOS +1.3%, MPC +1.3%, EQC +1.2%, SPG +1.1%, PSA +1.1%, GEHC +0.9%

Other news:

BEAM +7.3% (Eli Lilly (LLY) to acquire certain rights under BEAM's collaboration agreement with Verve Therapeutics (VERV))
VERV +5.1% (Eli Lilly (LLY) to acquire certain rights under BEAM's collaboration agreement with Verve Therapeutics (VERV))
ZYXI +4.8% (to evaluate potential strategic alternatives)
WE +3.9% (details Forbearance Agreement)
LLY +1.7% (Eli Lilly (LLY) to acquire certain rights under BEAM's collaboration agreement with Verve Therapeutics (VERV))
INST +1.6% (to acquire Parchment for $835 mln)
IMO +1.2% (announces terms of its substantial issuer bid for up to CAD1500000000 and receipt of exemptive relief )

Analyst comments: